Netarsudil Mesylate
Generic Name: netarsudil mesylate
Dosage form: POWDER. Active ingredients: NETARSUDIL MESYLATE (1 g/g). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: NETARSUDIL MESYLATE (1 g/g). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Allium Sativum, Arsenicum Album, Benzoicum Acidum, Berberis Vulgaris, Betula Verrucosa, Calcarea Carbonica, Carbolicum Acidum, Chelidonium Majus, Chlorinum, Citricum Acidum, Histaminum, Ichthyolum, Juniperus Communis, Lycopodium Clavatum, Mercurius Solubilis, Natrum Bicarbonicum, Sodium Hypochlorite, Solidago Virgaurea, Sulphur
allium sativum, arsenicum album, benzoicum acidum, berberis vulgaris, betula verrucosa, calcarea carbonica, carbolicum acidum, chelidonium majus, chlorinum, citricum acidum, histaminum, ichthyolum, juniperus communis, lycopodium clavatum, mercurius solubilis, natrum bicarbonicum, sodium hypochlorite, solidago virgaurea, sulphur
Calculi Dissolution Agent [EPC]
For temporary relief of minor: headache* fatigue* swollen tonsils* nausea* dizziness* itching* coughing* burning pains* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Brimonidine Tartrate Ophthalmic Solution, 0.15%
brimonidine tartrate ophthalmic solution, 0.15%
11 DESCRIPTION Brimonidine tartrate ophthalmic solution 0.15%, sterile, is a relatively selective alpha-2 adrenergic receptor agonist (topical intraocular pressure lowering agent). The structural formula of brimonidine tartrate is: 5-bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate; MW= 442.24 In solution, brimonidine tartrate ophthalmic solution has a clear, greenish-yellow color. It has an osmolality of 250-350 mOsmol/kg and a pH of 6.6-7.4.
Burn Relief
burn relief
Amide Local Anesthetic [EPC]
Purpose External analgesic
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.